Table 1.
Study Characteristics.
Author(s) | PICO Statement | Participants and Comparison Groups | Definition of Prepregnancy BMI and Obesity | Time Point for Microbiome Collection | Sample Sourcea | Quality Assessmentb |
---|---|---|---|---|---|---|
Biospecimens collected from mothers only | ||||||
Collado et al. (2008) | Do BMI and GWG alter the maternal gastrointestinal microbiota before delivery? |
N = 54 women:
|
BMI: Maternal self-report of weight at first clinic
visit Overweight/obesity: BMI > 30 kg/m2 |
First (10–15 weeks’ gestation) and third (30–35 weeks’ gestation) trimesters of pregnancy | Study | IIB |
Houttu et al. (2017) | Does the degree of overweight alter the composition of the maternal gastrointestinal microbiome during pregnancy? |
N = 99 women
|
BMI: Maternal self-report of weight at first clinic visit Obesity: BMI > 30 kg/m2 |
< 17 weeks’ gestation | Study | IIB |
Gomez-Arango et al. (2016a, 2016b) | Is there a difference in gut microbiome composition and circulating metabolic hormones between OW and OB pregnant women? |
N = 70 women
|
BMI: not reported Obesity: BMI > 30 kg/m2 |
16 weeks’ gestation | Study | IIB |
Santacruz et al. (2010) | Do body weight and GWGc alter the composition of the maternal gastrointestinal microbiome during pregnancy? |
N = 50 women
|
BMI: not reported Obesity: BMI > 25 kg/m2 |
24 weeks’ gestation | Study | IIB |
Smid et al. (2018) | Does EGWG change the maternal gastrointestinal microbiome during pregnancy? |
N = 31 women Groups: Above and below median GWG for this cohort, baseline and follow-up |
BMI: Weight at first clinic visit Obesity: BMI > 30 kg/m2 |
Baseline: < 20 weeks’ gestation Follow-up: 36−39 weeks’ gestation |
Study | IIIB |
Biospecimens collected from mothers and infants | ||||||
Chu et al. (2016) | Does maternal obesity alter the neonatal and infant gut microbiome in early life? |
N = 157 women, 157 infants Groups: High fat intake and control |
Not reported | First maternal and infant stool samples at 24−48 hr after delivery and second sample at 4−6 weeks of life | Study | IIB |
Stanislawski et al. (2017) | Is maternal prepregnancy overweight/obesity associated with differences in the maternal gastrointestinal microbiota at the time of delivery or in the gastrointestinal microbiota of their infants during the first 2 years of life? |
N = 169 women, 181 infants Groups: NW and OW/OB mothers |
BMI: Maternal self-report of weight at first clinic visit Overweight and obesity: BMI ≥ 25 kg/m2 |
Maternal sample 4 days after delivery, newborn samples at 6 time points over the first 2 years of life | Biobank | IIA |
Biospecimens collected from infants only | ||||||
Collado et al. (2010) | Do maternal BMI status and EGWG alter the microbiota of their infants? |
N = 42 infants, 26 NW mothers, 16 OW mothers Groups: OW and NW |
BMI: Maternal self-report of weight at first clinic visit Overweight: BMI ≥ 25 kg/m2 |
1 and 6 months of life | Study | IIA |
Galley et al. (2014) | Is maternal obesity associated with differences in the composition of the gut microbiome in children in early life? |
N = 77 infants, 25 OB mothers, 51 non-OB mothers Groups: OW and OB |
BMI: Not reported Obesity: BMI > 30 kg/m2 |
18–27 months of age | Study | IIB |
Mueller et al. (2016) | Is maternal prepregnancy BMI associated with differences in the gastrointestinal microbiota between infants delivered vaginally and those delivered via ECS? |
N = 74 neonates
|
BMI: Not reported Overweight and Obesity: > 25 kg/m2 |
2 days after delivery | Study | IIB |
Robinson et al. (2017) | Is GWGc associated with changes in infant fecal microbiota composition, bacterial-community richness, and Shannon diversity index? |
N = 84 infants Groups: GWG categories |
Not reported | <1 year of age | Biobank | IIB |
Note. Studies are arranged to highlight the population studied. BMI = body mass index; ECS = elective cesarean section; EGWG = excessive gestational weight gain; GWG = gestational weight gain; NW = normal weight; OB = obese; OW = overweight; PICO = population, intervention, comparison/control, outcome; VD = vaginal delivery.
aSamples were either sourced directly from a biobank or from a prospective cohort study. bThe quality assessment score includes level (Level I = randomized controlled trial or experimental study, Level II = quasi-experimental, Level III = nonexperimental, Level IV = qualitative) and quality assessment (A = high, B = good, or C = low quality) which was adapted from Keim-Malpass, Letzkus, and Kennedy (2015). cGWG was defined by the Institute of Medicine guidelines.